Funding Received
$38.8 Million in 2 Rounds from 6 Investors
Most Recent Funding
$31.5 Million Series B on March 28, 2012
Headquarters:
Mont-saint-guibert
Description:
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
Categories:
Biotechnology
Website:
http://www.promethera.com

Detailed Description

Update

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology.

Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers.

Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Current Team (2)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    Watson & Crick Hill

    Rue Granbonpré, 11

    Mont-saint-guibert, B-1435

    BEL

Images (1)

Update
  • F27936285838f7c6ddcf497201fb65d7